Venous thromboembolism (VTE) in children is an important clinical concern for which risk
factors include clinical conditions that incite venous stasis, endothelial damage, or …

Abstract Background Antithrombin [AT]-, protein C [PC]-or protein S [PS]-deficiency [D]
constitutes a major risk factor for venous thromboembolism [VTE]. Primary study objective …

Protein S (PS) deficiency is a risk factor for venous thromboembolism (VTE) and can be
caused by variants of the gene encoding PS (PROS1). This study aimed to evaluate the …

In neonates and infants with idiopathic venous thrombosis (VTE) and in pediatric
populations in which thromboses were associated with medical diseases, inherited …

Despite considerable advances in the identification of new risk factors for VTE, predicting the
risk of recurrence in an individual patient remains a challenge. The impact of many of these …

Technology in hemostasis laboratories has evolved enormously during the last 30 years.
Although many scientists and clinicians will remember the traditional tilt-tube techniques to …

Antithrombin (AT), a serin protease inhibitor (serpin) produced in the liver, inhibits mainly
thrombin and factor Xa. Antithrombin deficiency (AD) is associated with a higher incidence of …

Hintergrund: Die Bedeutung thrombophiler Gerinnungsstörungen für die Entstehung
venöser retinaler Gefäßverschlüsse wird immer noch kontrovers diskutiert. Patienten und …

Thromboembolic disease and obstetric complications related to ischemia of the placenta are
currently the major causes of maternalmortality and morbidity. Thrombophilia been …

The aim of this study was to assess the incidence and risk factors for recurrent venous
thromboembolism (VTE) in a Hispanic population. We prospectively followed 343 patients …